Press Releases April 20, 2026 04:05 PM

Amwell® to report first quarter 2026 operating results

Amwell schedules Q1 2026 results release and conference call for May 5

By Caleb Monroe AMWL
Amwell® to report first quarter 2026 operating results
AMWL

Amwell, a leading SaaS-based healthcare technology provider, announced it will report its Q1 2026 operating results after market hours on May 5, 2026, followed by a live webcast and conference call to discuss the company's performance and business updates.

Key Points

  • Amwell operates a comprehensive technology-enabled healthcare platform serving payers and health systems.
  • The platform powers multiple clinical programs and offers integrated, personalized, and scalable virtual care solutions.
  • The company will host an earnings webcast and conference call to provide detailed financial results and business insights.
  • The healthcare technology sector, particularly telehealth and SaaS platforms, is impacted by this development.

BOSTON, April 20, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report first quarter 2026 operating results after stock market trading hours on Tuesday, May 5.

Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.

The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.

About Amwell  
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Investors:

Asher Dewhurst

[email protected]

Media:

[email protected]


Risks

  • Uncertainty around financial performance which may affect investor sentiment post-earnings release.
  • Potential challenges in scaling and maintaining platform reliability as demand for virtual care increases.
  • Competition and regulatory risks within the healthcare technology and telemedicine markets.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026